WVE - Company ID 0001631574
The table below shows Wave Life Sciences Ltd.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $38.25M | - | $8.70M | $9.18M | - | $19.69M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $47.44M | $45.87M | $43.47M | $40.62M | $41.20M | $40.39M |
Wave Life Sciences Ltd. reported annual revenue of $42.73M for fiscal year 2025. That is down 60.5% from $108.30M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.49M (FY 2016) to $42.73M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $22.10M |
| $18.09M |
| $17.99M |
| $18.36M |
| $15.04M |
| $14.30M |
| Operating income | -$31.30M | -$56.35M | -$52.76M | -$49.80M | -$63.91M | -$35.00M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$26.09M | -$53.85M | -$50.47M | -$46.88M | -$61.78M | -$32.92M |
| EPS (diluted) | -$0.13 | -$0.32 | -$0.31 | -$0.29 | -$0.47 | -$0.25 |